Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.

The funding market, moving in real timeGet StartedBook a Demo
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Luna Genetics, Inc. announced it raised $4.88 Million in an initial filing from an offering of $5 Million

PRIVATEApr 25, 2022over 4 years ago

Amount Raised

$4.88 Million

Round Type

Seed

HoustonBiotechnology

Company Information

Company

Luna Genetics

Location

Houston, Texas, United States

About

Luna Genetics, Inc. is a company founded by doctors whose mission is to provide a better, safer, and more accurate way to provide prenatal genetic information to expectant parents. Luna’s first product, the Luna Prenatal Test, is a groundbreaking cell-based prenatal genetic test that isolates pure fetal DNA from rare fetal trophoblast cells circulating in maternal blood. This test is noninvasive and only requires a maternal blood sample, thus eliminating the risk of procedure-related pregnancy loss. The Luna Prenatal Test can be performed as early as 8 weeks gestation and provides patients with the most comprehensive information about their pregnancy available noninvasively. The Luna Prenatal Test detects clinically significant deletions and duplications down to a resolution of 1.5Mb and 2.0Mb, respectively, as well as all trisomies and monosomies. The Luna Prenatal test is an especially attractive option for patients who: -Conceived via IVF and want to confirm fetal genetics -Had a positive NIPT result and decline further invasive testing options -Want the earliest testing available -Have cultural or religious time limits to determine genetic health -Had a previous pregnancy or existing child with trisomy or deletion syndrome -Have Balanced Translocation

Predictive Intelligence
Strategic

ML-powered predictions for Luna Genetics's next move

Learn about Strategic plan

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.

Watching Luna Genetics? See every signal — funding, hires, M&A, contracts, sentiment.

Book a demoChoose your plan